KLHL36

Across TCGA pan-cancer cohorts, KLHL36 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated KLHL36 data layer compared with 25 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher KLHL36 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated KLHL36 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and LSCC show a favorable association.

HNSC, CCRCC, and OV are the cancer types where KLHL36 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	III,IV	0.291	1.000	.001	22	view →
CCRCC	DFS	Median	II,III,IV	0.969	0.776	.003	16	view →
OV	DFS	Median	All	0.409	1.000	.045	8	view →
LSCC	DFS	Quartile	All	0.856	0.207	.017	6	view →
GBM	OS	Tertile	All	0.739	0.385	.020	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

KLHL36–HNSC (DFS)

Open the HNSC breakdown →